# of Displayed Technologies: 2 / 2

Applied Category Filter (Click To Remove): Infectious Diseases


Categories

A novel STK1-targeted small molecule as an "antibiotic resistance breaker"
TS-037880 — Inh2-B1 serves as a therapeutically important “antibiotic-resistance-breaker,” which enhances the bactericidal activity of Ceftriaxone/Cefotaxime against highly pathogenic MDRSA infection.
Highly pathogenic and multidrug-resistant Staphylococcus aureus (MDRSA) encompasses methicillin-resistant strains of S. aureus that have developed resistance to multiple traditional antibiotics. Because of the recent emergence of antimicrobial resistance, MDRSA has been commonly incriminated in a …
  • College: College of Medicine (COM)
  • Inventors: Pancholi, Vijay
  • Licensing Officer: Paschall, Christopher

Selective Delipidation of Mycobacterium bovis BCG enhances its Vaccine Potential against TB
TS-037463 — A novel method to increase vaccine effectiveness for TB
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), is an infectious disease that kills one person every 21 seconds. TB is the current leading cause of death worldwide due to a single infectious organism, overtaking AIDS and malaria. TB treatment requires several months to years of che…
  • College: College of Medicine (COM)
  • Inventors: Torrelles, Jordi; Moliva, Juan
  • Licensing Officer: Norris, Francis "Frank"
PDF

Loading icon